Xconomy San Diego

Mpex Pharmaceuticals Secures $27,500,000 Series D Round

  • Feed Type
  • Date
    2/10/2009
  • Company Name
    Mpex Pharmaceuticals
  • Mailing Address
    11535 Sorrento Valley Road San Diego, CA 92121
  • Company Description
    Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens.
  • Website
    http://www.mpexpharma.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,500,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.